Skip to Main Content

Paper Details

Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.
Pediatr Blood Cancer
5
2021
B7, Bone Tumor, CD47, H3, Osteosarcoma, SIRP, bone tumor, children, osteosarcoma, telaglenastat, tyrosine, tyrosine kinase
Author NameAffiliation
Peter J HoughtonGreehy Children's Cancer Research Institute
Patrick J GroharChildren's Hospital of Philadelphia
Patrick J GroharChildren's Hospital of Philadelphia
Elizabeth StewartSt. Jude Children's Research Hospital
Elizabeth StewartSt. Jude Children's Research Hospital
Scott C BorinsteinVanderbilt University Medical Center
Richard GorlickUniversity of Texas MD Anderson Cancer Center
Richard GorlickUniversity of Texas MD Anderson Cancer Center
Katherine A JanewayDana-Farber Cancer Institute
  • 1 - 9

Datasets

Release 1.2